Artelo Biosciences (ARTL) stock rose nearly 600% after announcing an $11 million private placement of common stock units at $3.45 per share, including warrants. Proceeds will support working capital, corporate purposes, and bridge debt repayment.

NodeGuardian

2026-04-15 13:04:22

Abstract generation in progress

Artelo Biosciences (ARTL) stock surged approximately 600% following the announcement of an $11 million private placement. The deal, priced at-the-market under Nasdaq rules, involves the sale of 3,188,407 common stock units at $3.45 per share, coupled with warrants for an additional 6,376,814 shares. The net proceeds are earmarked for working capital, general corporate purposes, and the repayment of bridge debt.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
120.82K Popularity
#
GateMarchTransparencyReport
42.42K Popularity
#
GoldmanSachsFilesBitcoinIncomeETF
775.75K Popularity
#
USBlocksStraitofHormuz
749.22K Popularity
#
WCTCTradingChallengeShare8MUSDT
614.12K Popularity

Sitemap

Artelo Biosciences (ARTL) Stock Jumps 600% on $11M Private Placement

Trending Topics

GatePreIPOsLaunchesWithSpaceX

GateMarchTransparencyReport

GoldmanSachsFilesBitcoinIncomeETF

USBlocksStraitofHormuz

WCTCTradingChallengeShare8MUSDT

Pin